Article Versions Notes

Bahetibieke S, Moinuddin SM, Baiyisaiti A, Liu X, Zhang J, Liu G, Shi Q, Peng A, Tao J, Di C, et al. Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice. Pharmaceutics. 2022; 14(6):1258. https://doi.org/10.3390/pharmaceutics14061258

Bahetibieke, Shamuha, Sakib M. Moinuddin, Asiya Baiyisaiti, Xiaoang Liu, Jie Zhang, Guomin Liu, Qin Shi, Ankang Peng, Jun Tao, Chang Di, and et al. 2022. "Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice" Pharmaceutics 14, no. 6: 1258. https://doi.org/10.3390/pharmaceutics14061258

Bahetibieke, S., Moinuddin, S. M., Baiyisaiti, A., Liu, X., Zhang, J., Liu, G., Shi, Q., Peng, A., Tao, J., Di, C., Cai, T., & Qi, R. (2022). Co-Amorphous Formation of Simvastatin-Ezetimibe: Enhanced Physical Stability, Bioavailability and Cholesterol-Lowering Effects in LDLr−/−Mice. Pharmaceutics, 14(6), 1258. https://doi.org/10.3390/pharmaceutics14061258